Study of endothelial dysfunction and its correlation with disease activity in systemic lupus erythematosus patients without conventional cardiovascular risk factors
Article Outline
Abstract
Background
Endothelial dysfunction is an important cause of cardiovascular morbidity and mortality in patients of systemic lupus erythematosus (SLE), causing atherosclerosis and its related complications, even in the absence of conventional cardiovascular risk factors.
Objective
The present study was aimed at finding the prevalence of endothelial dysfunction in SLE and its relation with disease activity.
Methods
Fifty SLE patients without traditional cardiovascular risk factors, and equal number of age and sex matched controls were chosen. Endothelial function was assessed by flow mediated vasodilatation (FMV) on brachial artery using B-mode ultrasonography.
Results
Mean age of SLE patients was 26.06 ± 6.231 years. Thirty-seven (74%) of the patients were having severe disease activity, defined as systemic lupus erythematosus disease activity index (SLEDAI) >8. We found significantly lower levels of basal brachial artery diameter in SLE patients (0.3499±0.075 cm) compared to controls (0.3826 ± 0.0002cm), as also impaired FMV (2.57 ± 2.32% and 8.7082 ± 1.5776%, respectively). Flow mediated vasodilatation significantly correlated with SLEDAI (r=-0.52) and complement (C3) levels (r=0.33).
Conclusion
Endothelial dysfunction in SLE correlates with disease activity.
Keywords: Endothelial dysfunction , SLEDAI , complement level , flow mediated vasodilatation
No full text is available. To read the body of this article, please view the PDF online.
References
- . Pathogenesis of systemic lupus erythematosus . J Clin Pathol . 2003;56:481–490
- Systemic lupus erythematosus in three ethnic groups, III: a comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: Nature vs. Nurture . Lupus . 1999;8:197–209
- . Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus . Arthritis Rheum . 1999;42:338–346
- . Premature atherosclerosis in systemic lupus erythematosus . Rheum Dis Clin North Am . 2000;26:257–278
- . Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparision with the Framingham study . Am J Epidemiol . 1997;145:408–415
- . Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythemato-sus . N Engl J Med . 2003;349:2399–2406
- Systemic lupus erythematosus an independent risk factor for endothelial dysfunction in women . Circulation . 2004;110:399–404
- . Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus . Ann Rheum Dis . 1987;46:741–745
- Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodialation at the brachial artery . J Am Coll Cardiol . 2002;39:257–265
- . A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus . J Rheumatol . 1993;20:657–660
- Endothelial dysfunction in systemic lupus erythematosus . Romanian J Biophys . 2008;18:237–244
- The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum . 1982;25:1271–1277
- . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter] . Arthritis Rheum . 1997;40:1725
- . Measurement of endothelial function by brachial artery flow-mediated vasodilation . Am J Cardiol . 2001;88:31E–34E
- Permarheum SLEDAI calculator [internet]. Permanente Rheumatology Association; 2010: [about 1 p]. [Cited 2010] . Available online at http://permarheum.org/SLEDAI.html
- . Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto risk factor study . Arthritis Rheum . 2003;48:3159–3167
- . Lupus and cardiovascular disease: the facts . Lupus . 2006;15(Suppl):3–10
- . Antibodies to oxidised LDL . Lupus . 2000;9:202–205
- . Does ADMA cause endothelial dysfunction? . Arterioscler Thromb Vasc Biol . 2000;20:2032–2037
- Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus . Arthritis Rheum . 2007;56:3759–3769
- . Anti-endothelial cell antibodies in systemic lupus erythematosus . Int J Rheum Dis . 2008;11:121–126
- A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus . Lupus . 2009;18:235–242
- . Brachial endothelial function is impaired in patients with systemic lupus erythematosus . J Rheumatol . 2002;29:292–297
- Atherosclerosis in Asian Indians with systemic lupus erythematosus . Scand J Rheumatol . 2006;35:128–132
- . Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythemato-sus . Clin Rheumatol . 2009;28:1259–1265
- Peripheral vascular disease in systemic lupus erythematosus . Lupus . 2007;16:720–723
- Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity . Blood . 2004;103:3677–3683
- . Endothelial function and bradykinin in humans . Drugs . 1997;54:42–47
- Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus . Arterioscler Thromb Vasc Biol . 2006;26:2281–2287
- Endothelial function in systemic lupus erythematosus: relationship to disease activity, cardiovascular risk factors, corticosteroid therapy, and coronary calcification . Vasc Health Risk Manag . 2005;1:357–360
PII: S0973-3698(11)60204-5
doi:10.1016/S0973-3698(11)60204-5
© 2011 Indian Rheumatology Association. Published by Elsevier Inc. All rights reserved.
